Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Maternal and fetal prognosis of subsequent pregnancy in black African women with peripartum cardiomyopathy |
Type de publication | Journal Article |
Year of Publication | 2018 |
Auteurs | Yameogo NValentin, Samadoulougou AKoudnoaga, Kagambega LJustine, Kologo KJonas, Millogo GRosario Ch, Thiam A, Guenancia C, Zansonre P |
Journal | BMC CARDIOVASCULAR DISORDERS |
Volume | 18 |
Pagination | 119 |
Date Published | JUN 18 |
Type of Article | Article |
ISSN | 1471-2261 |
Mots-clés | Burkina Faso, Peripartum cardiomyopathy, prognosis, Subsequent pregnancy |
Résumé | {Background: The aim of this study was to describe maternal and fetal outcomes after pregnancy complicated by peripartum cardiomyopathy (PPCM). Methods: We included women that had subsequent pregnancy (SSP) after PPCM and assessed maternal prognosis and pregnancy outcomes, in-hospital up to one week after discharge. Clinical and echocardiographic data were collected comparing alive and deceased women. Factors associated with pregnancy outcomes were assessed. Results: Twenty-nine patients were included, with a mean age of 26.7 +/- 4.6 years and a mean gravidity number of 2.3 +/- 0.5 of. At the last medical control before subsequent pregnancy, there was no congestive heart failure, the mean left ventricular diastolic diameter (LVDD) was 53 +/- 4 mm and the left ventricular ejection fraction (LVEF) was >= 50% in 13 cases (44.8%). Maternal outcomes were marked by 14 deaths (48.3%). Among the factors tested in univariate analysis, LVEF at admission had an excellent receiver-operating characteristic (ROC) curve to predict maternal mortality (AUC = 0.95; 95% CI 0.87-1, p < 0.001), with a cut off value of < 40% (sensitivity = 93% and specificity = 87%). Concerning fetal outcomes, baseline LVEF had the best area under the curve (AUC) to predict abortion or prematurity among all variables (AUC = 0.75; 95% CI 0.58-092 |
DOI | 10.1186/s12872-018-0856-7 |